Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid.

Literature DB >> 6980625

beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid.

Abstract

Three of four clinical isolates of Branhamella catarrhalis from Belgium produced a beta-lactamase identical to enzymes previously reported to occur in French and British isolates of this organism. One strain, however, produced a new type of beta-lactamase. Both beta-lactamase types were readily inhibited by low concentrations of clavulanic acid.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1982 PMID： 6980625 PMCID： PMC181924 DOI： 10.1128/AAC.21.3.506

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

11 in total

1. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors: C Reading; M Cole
Journal: Antimicrob Agents Chemother Date: 1977-05 Impact factor: 5.191

2. Novel beta-lactamase from Branhamella catarrhalis.

Authors: A B Hoi-Dang; C Brive-Le Bouguenec; M Barthelemy; R Labia
Journal: Ann Microbiol (Paris) Date: 1978-10

3. Fatal Neisseria (Branhamella) catarrhalis pneumonia in an immunodeficient host.

Authors: D J McNeely; C S Kitchens; R M Kluge
Journal: Am Rev Respir Dis Date: 1976-08

4. Branhamella (Neisseria) catarrhalis as pathogen.

Authors: G Ninane; J Joly; P Piot; M Kraytman
Journal: Lancet Date: 1977-07-16 Impact factor: 79.321

5. In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis.

Authors: B E Malmvall; J E Brorsson; J Johnsson
Journal: J Antimicrob Chemother Date: 1977-07 Impact factor: 5.790

6. Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis.

Authors: A Percival; J E Corkill; J Rowlands; R B Sykes
Journal: Lancet Date: 1977-12-03 Impact factor: 79.321

7. Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.

Authors: G Ninane; J Joly; M Kraytman; P Piot
Journal: Lancet Date: 1978-07-29 Impact factor: 79.321

8. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.

Authors: G Ninane; J Joly; M Kraytman
Journal: Br Med J Date: 1978-02-04

9. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors: C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal: Antimicrob Agents Chemother Date: 1972-04 Impact factor: 5.191

10. Inhibition of the -lactamases of Escherichia coli and Klebsiella aerogenes by semi-synthetic penicillins.

Authors: M Cole; S Elson; P D Fullbrook
Journal: Biochem J Date: 1972-03 Impact factor: 3.857

27 in total

1. Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.

Authors: S S Richter; P L Winokur; A B Brueggemann; H K Huynh; P R Rhomberg; E M Wingert; G V Doern
Journal: Antimicrob Agents Chemother Date: 2000-02 Impact factor: 5.191

Review 2. Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4.

Authors: K Bush
Journal: Antimicrob Agents Chemother Date: 1989-03 Impact factor: 5.191

3. Interaction of Streptococcus pneumoniae and Moraxella catarrhalis: investigation of the indirect pathogenic role of beta-lactamase-producing moraxellae by use of a continuous-culture biofilm system.

Authors: R K Budhani; J K Struthers
Journal: Antimicrob Agents Chemother Date: 1998-10 Impact factor: 5.191

4. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study.

Authors: G V Doern; A B Brueggemann; G Pierce; T Hogan; H P Holley; A Rauch
Journal: Antimicrob Agents Chemother Date: 1996-12 Impact factor: 5.191

Review 5. [Moraxella catarrhalis: virulence and resistance mechanisms].

Authors: W Cullmann
Journal: Med Klin (Munich) Date: 1997-03-15

6. Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis.

Authors: E E Stobberingh; H J van Eck; A W Houben; C P van Boven
Journal: Drugs Date: 1986 Impact factor: 9.546

7. Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.

Authors: R Labia; M Barthelemy; C B Le Bouguennec; A Buu Hoi-Dang Van
Journal: Drugs Date: 1986 Impact factor: 9.546

8. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors: R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal: Antimicrob Agents Chemother Date: 1989-11 Impact factor: 5.191

Review 9. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors: K McGregor; B J Chang; B J Mee; T V Riley
Journal: Eur J Clin Microbiol Infect Dis Date: 1998-04 Impact factor: 3.267

10. Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.

Authors: H J Bootsma; H van Dijk; J Verhoef; A Fleer; F R Mooi
Journal: Antimicrob Agents Chemother Date: 1996-04 Impact factor: 5.191